Abstract
The objective of the present study was to investigate the effects of chronic activation of dopamine D2 receptors on the development of grafted fetal rat mesencephalic dopaminergic neurons. Therefore, unilaterally 6-hydroxydopamine — lesioned rats received intrastriatal mesencephalic cell suspension grafts and were subsequently chronically treated with the selective dopamine D2 receptor agonist LY 171555 (Quinpirole). After treatment for 6 consecutive weeks, the rats were processed for tyrosine-hydroxylase immunocytochemistry to assess the survival and outgrowth from grafted dopaminergic neurons. Morphological analysis revealed that, like the volume and morphology of the graft, neither the number nor the cell area of grafted dopaminergic neurons was significantly different between vehicle- and LY 171555-treated animals. To obtain a quantitative estimate of the graft-derived dopaminergic reinnervation, a computerized image analysis system was used. Using this procedure, which was based on the densitometric measurement of tyrosine hydroxylase immunoreactivity in the area adjacent to the grafted tissue, it was found that the extent of graft-derived outgrowth also appeared to be un-affected upon chronic treatment with LY 171555. It is concluded that long-term concurrent administration of a dopamine D2 receptor agonist for 6 consecutive weeks does not impair the survival and outgrowth of grafted rat fetal mesencephalic dopaminergic neurons.
Similar content being viewed by others
References
Abrous N, Guy J, Vigny A, Calas A, Le Moal M, Herman JP (1988) Development of intracerebral dopaminergic grafts: a combined immunohistochemical and autoradiographic study of its time course and environmental influences. J Comp Neurol 273:26–41
Benno RH, Tucker LW, Joh TH, Reis DJ (1982) Quantitative immunocytochemistry of tyrosine hydroxylase in rat brain. I. Development of a computer assisted method using the peroxidase-antiperoxidase technique. Brain Res 246:225–236
Björklund A (1992) Dopaminergic transplants in experimental Parkinsonism: cellular mechanisms of graft-induced functional recovery. Curr Opin Neurobiol 2:683–689
Björklund A, Dunnett SB, Stenevi U, Lewis ME, Iversen SD (1980) Reinnervation of the denervated striatum by substantia nigra transplants: functional consequences as revealed by pharmacological and sensorimotor testing. Brain Res 199:307–333
Blunt S, Jenner P, Marsden CD (1991a) The effect of chronic ldopa treatment on the recovery of motor function in 6-hydroxydopamine-lesioned rats receiving ventral mesencephalic grafts. Neuroscience 40:453–464
Blunt S, Jenner P, Marsden CD (1991b) The effect of l-dopa and carbidopa treatment on the survival of rat foetal dopamine grafts assessed by tyrosine hydroxylase immunohistochemistry and 3H-Mazindol autoradiography. Neuroscience 43:95–110
Blunt S, Jenner P, Marsden CD (1992) Motor function, graft surival and gliosis in rats with 6-OHDA lesions and foetal ventral mesencephalic grafts chronically treated with l-Dopa and carbidopa. Exp Brain Res 88:326–340
Bolam JP, Freund TF, Björklund A, Dunnett SB, Smith AD (1987) Synaptic input and local output of dopaminergic neurons in grafts that functionally reinnervate the host striatum. Exp Brain Res 68:131–146
Brundin P, Strecker RE (1991) Preparation and intracerebral grafting of dissociated fetal brain tissue in rats. In: Conn PM (ed) Lesions and transplantation. (Methods in neurosciences, vol 7) Academic Press, San Diego, pp 305–326
Carvey PM, Ptak LR, Kao LC, Klawans HL (1989) Striatal homogenates from animals chronically treated with haloperidol stimulate dopamine and GABA uptake in cultures of rostral mesencephalic tegmentum. Clin Neuropharmacol 12:425–434
Carvey PM, Ptak LR, Lo ES, Lin D, Buhrfiend CM, Goetz CG, Klawans HL (1991) Levodopa reduces the growth promoting effects of striatal extracts on rostral mesencephalic tegmental cultures. Exp Neurol 114:28–34
Carvey PM, Ptak LR, Nath ST, Sierens DK, Mufson EJ, Goetz CG, Klawans HL (1993) Striatal extracts from patients with Parkinson's disease promote dopamine neuron growth in mesencephalic cultures. Exp Neurol 120:149–152
Dolleman-Van der Weel MJ, Nijssen A, Steinbusch HWM (1993) Morphological and behavioral drawbacks of fetal dopaminergic grafts, prelabeled with Phaseolus vulgaris Leucoagglutinin. Exp Neurol 122:260–272
Doucet G, Murata Y, Brundin P, Bosler O, Mons N, Geffard M, Ouimet CC, Björklund A (1989a) Host afférents into intrastriatal transplants of fetal ventral mesencephalon. Exp Neurol 106:1–19
Doucet G, Brundin P, Seth S, Murata Y, Strecker RE, Triarhou LC, Ghetti B, Björklund A (1989b) Degeneration and graft-induced restoration of dopamine innervation in the weaver neostriatum: a quantitative radiographie study of [3H]dopamine uptake. Exp Brain Res 77:552–568
Farm S, Cohen G (1992) The oxidant stress hypothesis in Parkinson's disease: evidence supporting it. Ann Neurol 32:804–812
Felten DL, Felten SY, Fuller RW, Romano TD, Smalstig EB, Wong DT, Clemens JA (1992) Chronic dietary pergolide preserves nigrostriatal neuronal integrity in aged Fischer-344 rats. Neurobiol Aging 8:233–239
Filloux F, Townsend JJ (1993) Pre- and postsynaptic neurotoxic effects of dopamine demonstrated by intrastriatal injection. Exp Neurol 119:79–88
Gallick Whitaker NG, Lindstrom TD (1987) Disposition and biotransformation of quinpirole, a new D-2 dopamine agonist antihypertensive agent, in mice, rats, dogs, and monkeys. Drug Metab Dispos 15:107–113
Hornykiewicz O (1988) Neurochemical pathology and the etiology of Parkinson's disease: basic facts and hypothetical possibilities. Mt Sinai J Med 55:11–20
Lindvall O (1994) Transplantation — the clinical position. In: Marsden CD, Fahn S (eds) Movement disorders, vol 3. Butterworth-Heinemann, Oxford, pp 226–261
Manier M, Abrous DN, Feuerstein C, Le Moal M, Herman JP (1991) Increase of striatal methionin enkephalin content following lesion of the nigrostriatal dopaminergic pathway in adult rats and reversal following the implantation of embryonic dopaminergic neurons: a quantitative immunohistochemical analysis. Neuroscience 42:427–439
Marsden CD, Parkes JD (1977) Success and problems of long-term levodopa therapy in Parkinson's disease. Lancet 12:345–349
Mytilineou C, Han S-K, Cohen G (1993) Toxic and protective effects of l-dopa on mesencephalic cell cultures. J Neurochem 61:1470–1478
Paxinos G, Watson C (1982) The rat brain in stereotaxic coordinates. Academic Press, Sydney
Rabey JM, Passeltiner P, Markey K, Asano T, Goldstein M (1981) Stimulation of pre- and postsynaptic dopamine receptors by an ergoline and by a partial ergoline. Brain Res 225:347–356
Sauer H, Brundin P (1991) Effects of cool storage on survival and function of intrastriatal ventral mesencephalic grafts. Restor Neurol Neurosci 2:123–135
Savasta M, Mennicken F, Chritin M, Abrous DN, Feuerstein C, Le Moal M, Herman JP (1992) Intrastriatal dopamine-rich implants reverse the changes in dopamine D-2 receptor densities caused by 6-hydroxydopamine lesion of the nigrostriatal pathway in rats: an autoradiographic study. Neuroscience 46:729–738
Schmidt RH, Ingvar M, Lindvall O, Stenevi U, Björklund A (1982) Functional activity of substantia nigra reinnervating the striatum: neurotransmitter metabolism and (14C)2-deoxy-dglucose autoradiography. J Neurochem 38:737–748
Steece-Collier K, Collier TJ, Sladek CD, Sladek JR Jr (1990) Chronic levodopa impairs morphological development of grafted embryonic dopamine neurons. Exp Neurol 110:201–208
Sternberger LA, Sternberger NH (1986) The unlabeled antibody method: comparison of peroxidase-antiperoxidase with avidinbiotin complex by a new method of quantification. J Histochem Cytochem 34:599–605
Strecker RE, Sharp T, Brundin P, Zetterström T, Ungerstedt U, Björklund A (1987) Autoregulation of dopamine release and metabolism by intrastriatal nigral grafts as revealed by intracerebral dialysis. Neuroscience 22:169–178
Van Muiswinkel PL, Drukarch B, Steinbusch HWM, Stoof JC (1993) Chronic dopamine D-2 receptor activation does not affect survival and outgrowth of cultured dopaminergic neurons: morphological and neurochemical observations. J Neurochem 60:83–92
Van Muiswinkel FL, Drukarch B, Steinbusch HWM, Stoof JC (1994) Dopamine D-2 autoreceptors regulating the release of dopamine from cultured rat fetal dopaminergic neurons do not desensitize upon sustained activation: implications for the combined pharmaco- and grafting therapy in Parkinsonian patients. Exp Neurol 125:218–227
Van Muiswinkel FL, Jongenelen CAM, Schepens HTWJ, Stoof JC, Drukarch B (1995) Effects of chronic activation of dopamine D-2 receptors in cultures of rat fetal dopaminergic neurons: indications for alterations in functional activity. Dev Brain Res 85:128–136
Widner H, Tetrad J, Rehncrona S, Snow B, Brundin P, Gustavii B, Björklund A, Lindvall O, Langsten JW (1992) Bilateral fetal mesencephalic grafting in two patients with Parkinsonism induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydrophyridine (MPTP). N Engl J Med 327:1556–1563
Yurek DM, Steece-Collier C, Collier TJ, Sladek JR Jr (1991) Chronic levodopa impairs the recovery of dopamine agonistinduced rotational behavior following neural grafting. Exp Brain Res 86:97–107
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Van Muiswinkel, F.L., Bol, J.G.J.M., Ruijter, J.M. et al. Repeated administration of a selective dopamine D2 receptor agonist to 6-OHDA — lesioned rats does not affect the survival and outgrowth of intrastriatal fetal mesencephalic grafts. Exp Brain Res 107, 52–58 (1995). https://doi.org/10.1007/BF00228016
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00228016